Sanofi SA (SASY.PA)

SASY.PA on Paris Stock Exchange

87.16EUR
6 Jul 2015
Change (% chg)

-- (--)
Prev Close
€87.16
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
3,305,751
52-wk High
€99.23
52-wk Low
€69.58

SASY.PA

Chart for SASY.PA

About

Sanofi is a healthcare company focused on patient needs and engaged in the research, development, manufacture and marketing of healthcare products. The Company is organized around three principal activities: Pharmaceuticals, Human Vaccines via Sanofi Pasteur, and Animal Health via Merial. The Company invests in emerging markets,... (more)

Overall

Beta: 0.69
Market Cap(Mil.): €116,189.70
Shares Outstanding(Mil.): 1,317.53
Dividend: 2.85
Yield (%): 3.23

Financials

  SASY.PA Industry Sector
P/E (TTM): 27.21 35.83 39.81
EPS (TTM): 3.24 -- --
ROI: -- 17.03 16.23
ROE: -- 17.93 17.36
Search Stocks

French and Benelux stocks-Factors to watch on July 3

PARIS, July 3 - Below are company-related news and stories from French and Benelux media which could have an impact on the region's markets or individual stocks.

03 Jul 2015

European Factors to Watch - Shares seen mixed with Greek vote, PMIs in focus

(Adds futures, detail, company news) LONDON, July 3 - European stocks were seen opening mixed on Friday ahead of economic survey data later in the session, with focus on the Greek debt crisis heading into a crunch vote at the weekend. As angry and uncertain voters prepare for a referendum on Sunday that could decide Greece's future in Europe, the International Monetary Fund delivered a stark warning on Thursday of the huge financial hole facing the country. A new opini

03 Jul 2015

BRIEF-Sanofi's new basal insulin lantus xr aproved in Japan

* Says new basal insulin lantus xr, known as toujeo in the u.s. and Europe approved in Japan for the treatment of diabetes mellitus. Source text for Eikon: Further company coverage: (Reporting By Dominique Vidalon)

03 Jul 2015

Zhejiang Hisun Pharma teams up Sanofi on developing diabetes-related treatment

* Says signed non-binding MOU with Sanofi SA to set up a joint venture in China focusing on developing insulin and diabetes-related treatment

03 Jul 2015

BRIEF-Teleste to deliver broadband network to dutch operator Delta

* Signed an agreement with Delta for delivery of a next generation optical broadband network

01 Jul 2015

UPDATE 1-New Sanofi CEO to unveil five-year plan in November -unions

PARIS, June 26 - Sanofi Chief Executive Olivier Brandicourt has told unions he will present a five-year strategic plan in November after the French company's third-quarter results, labour representatives said.

26 Jun 2015

Sanofi five-year plan to be unveiled in November -unions

PARIS, June 25 - Sanofi Chief Executive Olivier Brandicourt has told unions he will present a five-year strategic plan in November after the French company's third-quarter results, labour representatives said on Thursday.

26 Jun 2015

MOVES-Bertarelli's Waypoint hires ex-Sanofi CEO to lead health fund

June 23 - Waypoint Capital, the investment vehicle backed by biotech guru Ernesto Bertarelli, appointed former chief executive of Sanofi SA, Christopher Viehbacher, as a managing partner to its U.S.-based healthcare investment fund.

23 Jun 2015

Woodford exits bets on Sanofi, adds drug, tech firms

LONDON, June 11 - Woodford Investment Management sold out of French pharmaceutical firm Sanofi in May on valuation grounds, the money manager said on Thursday, and instead added several smaller firms to its main fund.

11 Jun 2015

FDA panel backs Sanofi/Regeneron cholesterol drug with limits

(This version of the June 9th story corrects dosing schedule in last paragraph to every other week)

11 Jun 2015

Earnings vs. Estimates

Search Stocks